BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 23, 2025
Home » Authors » Jim Stommen

Articles by Jim Stommen

The MDD Interview: Head of Pennsylvania Bio hails growth in the life sciences sector

Nov. 21, 2012
By Jim Stommen
Christopher Molineaux is president of Pennsylvania Bio, the only statewide trade association for the life sciences industry whose membership includes medical device, diagnostic, biotechnology, pharmaceutical and research organizations. Prior to joining Pennsylvania Bio in September 2009, he served as worldwide VP of pharmaceutical communication and public affairs for Johnson & Johnson.
Read More

The MDD Interview: Chronic disease management cited as key market for VitalSims

Nov. 15, 2012
By Jim Stommen
Chris Duncan is CEO and a director of Vital Simulations (VitalSims; Edina, Minnesota), a company that develops and distributes web and iPad-based interactive simulation titles using virtual scenarios to improve learning outcomes.
Read More

The MDD Interview: Serious gaming seen as a key in training healthcare professionals

Nov. 8, 2012
By Jim Stommen
Chris Duncan is CEO and a director of Vital Simulations (VitalSims; Edina, Minnesota), a company that develops and distributes web and iPad-based interactive simulation titles using virtual scenarios to improve learning outcomes. Chris has more than 25 years in start-up and business management experience including serving as CEO of QuickStep Games, a developer of active play video games; managing partner of Ice Studios, a new media video production house; and former president of Dexxon Capital Corp., a business finance company.
Read More

The MDD Interview: Emerick cites culture of 'teamwork, humility' as key drivers for his firm

Nov. 1, 2012
By Jim Stommen

The MDD Interview: Company rises from garage roots to thrive as a medical supplier

Oct. 25, 2012
By Jim Stommen

The MDD Interview: Allen on hospital safety: 'You have to engage everyone in process'

Oct. 18, 2012
By Jim Stommen
Steve Allen, MD, has been CEO of Nationwide Children's Hospital in Columbus, Ohio, since July 2006. Allen is credited to driving the hospital's national prominence resulting in recognition as one of the best children's hospitals by both U.S. News and World Report and Parent magazine. Prior to coming to Columbus, Steve was a physician, scientist, teacher and executive in the Texas Medical Center in Houston for 24 years. He is board-certified in anesthesiology and critical care medicine.
Read More

The MDD Interview: Ohio-born hospital safety effort spreading the message nationally

Oct. 11, 2012
By Jim Stommen
Steve Allen, MD, has been CEO of Nationwide Children's Hospital in Columbus, Ohio, since July 2006. Allen is credited to driving the hospital's national prominence resulting in recognition as one of the best children's hospitals by both U.S. News and World Report and Parent magazine. Prior to coming to Columbus, Steve was a physician, scientist, teacher and executive in the Texas Medical Center in Houston for 24 years. He is board-certified in anesthesiology and critical care medicine.
Read More

The MDD Interview: Broadened role ahead for Indiana Health Information Exchange

Oct. 4, 2012
By Jim Stommen

The MDD Interview: Apple: 'Community effort' led to what is now the nation's largest HIE

Sep. 27, 2012
By Jim Stommen
Harold Apple is CEO and president of the Indiana Health Information Exchange, the nation's largest HIE organization. IHIE connects the state's hospitals, physicians, long-term care facilities and other healthcare providers, enabling medical information to follow patients regardless of treatment location to improve care coordination and patient outcomes. Physicians in the IHIE network provide care to more than 10 million patients.
Read More

The MDD Interview: Springboard Enterprises helps women entrepreneurs get funding

Sep. 13, 2012
By Jim Stommen
Kay Koplovitz is chairman and co-founder of Springboard Enterprises, a platform where entrepreneurs, investors and industry experts meet to build women-led businesses. Springboard educates, sources, coaches, showcases and supports high-growth companies seeking equity capital for expansion. She also is chairman/CEO of Koplovitz & Co. Koplovitz was the founder of cable TV networks USA Network, the Sci-Fi Channel and USA Networks International. She talked with MDD Contributing Writer Jim Stommen about Springboard's push for women entrepreneurs.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 … 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 22, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 22, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing